After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.
from Pocket https://www.nytimes.com/2019/10/22/health/alzheimers-dementia-aducanumab.html
via TV Aerials Leeds
No comments:
Post a Comment